• (Add Comment)

Xanoxiban 10 mg 10 tablets

130£

View analogs
  • Prevention of stroke and systemic thromboembolism in patients with non-valvular atrial fibrillation.
  • Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE).
  • Prevention of recurrent DVT and PE.

Buy

Product quantities

• Sharm El Sheikh: In stock
• Hurghada: Running out
• Al alamein: Running out
• Cairo: Running out

Form of Release: Tablets

Xanoxiban 10 mg 10 tablets

Composition:

Each tablet contains:
Rivaroxaban 10 mg.
Excipients:
Microcrystalline cellulose, croscarmellose sodium, hypromellose 5 cP, lactose monohydrate, magnesium stearate, sodium lauryl sulfate.

Product Description:

Xanoxiban is a highly selective direct inhibitor of Factor Xa with high oral bioavailability.
Inhibition of Factor Xa prevents thrombin formation and fibrin clot development, reducing the risk of thrombosis.

Properties:

  • Highly selective inhibition of Factor Xa.
  • Prevention of the “thrombin burst.”
  • Influence on laboratory coagulation parameters.

Indications for Use:

  • Prevention of stroke and systemic thromboembolism in patients with non-valvular atrial fibrillation.
  • Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE).
  • Prevention of recurrent DVT and PE.

Method of Administration and Dosage:

  • The preparation should be taken with food.
  • Stroke and thromboembolism prevention: 20 mg once daily.
  • Patients with renal impairment (CrCl 30–49 ml/min): 15 mg once daily.
  • Treatment of acute DVT/PE: 15 mg twice daily for 3 weeks, then 20 mg once daily.
  • After ≥6 months of therapy: 10 mg or 20 mg once daily depending on risk balance.

Contraindications:

  • Hypersensitivity to rivaroxaban or excipients.
  • Active bleeding.
  • Conditions with high bleeding risk (ulcers, tumors, CNS trauma).
  • Concomitant use of other anticoagulants (except transition schemes).
  • Liver disease with coagulopathy.
  • Severe renal impairment (CrCl <15 ml/min).
  • Pregnancy and breastfeeding.
  • Age under 18 years.
  • Hereditary lactose intolerance.

Precautions:

  • Not recommended with strong CYP3A4 and P-glycoprotein inhibitors (ketoconazole, ritonavir).
  • Use with caution in moderate renal impairment.
  • Possible interaction with azole antifungals (fluconazole has less pronounced effect).

Adverse Reactions:

  • Anemia, bleeding (eye, GI, urogenital tract, nosebleeds).
  • Dyspepsia, nausea, diarrhea, constipation, vomiting.
  • Fever, peripheral edema, weakness.
  • Elevated transaminases.
  • Headache, dizziness.
  • Skin reactions: itching, rash, ecchymosis.
  • Arterial hypotension, hematoma.

Pregnancy and Lactation:

Contraindicated during pregnancy and breastfeeding.

Storage Conditions:

Store at temperatures not exceeding 30°C in a dry place.

Packaging:

Cardboard box containing 1 blister of 10 tablets.

Active Ingredients:

No comments yet. Be the first to write one.

Leave a Comment

Your comment will be published after moderation.
You’ll receive a notification to your email when someone replies.

I'm not a robot

Related Products

Articles about the product